--- title: "Beijing Luzhu Biotechnology Co. (2480) stock and investor profile" url: "https://aibio.space/companies/beijing-luzhu-biotechnology/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Beijing Luzhu Biotechnology Co., Ltd. (HKEX: 2480), China. The directory classifies it as Biotechnology." --- 2480 Beijing Luzhu Biotechnology Co., Ltd. HKEX · China # Beijing Luzhu Biotechnology Co. (2480) news Beijing Luzhu Biotechnology Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2480, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Beijing Luzhu Biotechnology Co. news We have not published a story on Beijing Luzhu Biotechnology Co. yet. When there is news, it will appear here. ## Beijing Luzhu Biotechnology Co. at a glance - **Ticker**: 2480 - **Listing**: HKEX - **Country**: China ### Related companies - [Anhui Huaheng Biotechnology Co.](https://aibio.space/companies/anhui-huaheng-biotechnology/) SSE: 688639 - [CanSino Biologics](https://aibio.space/companies/cansino-biologics/) SSE: 688185 - [Shaanxi Micot Pharmaceutical Technology Co.](https://aibio.space/companies/shaanxi-micot-pharmaceutical-technology/) HKEX: 2335 - [Frontier Biotechnologies](https://aibio.space/companies/frontier-biotechnologies/) SSE: 688221 - [Boji Medical Technology Co.](https://aibio.space/companies/boji-medical-technology/) SZSE: 300404 - [Hebei Changshan Biochemical Pharmaceutical Co.](https://aibio.space/companies/hebei-changshan-biochemical-pharmaceutical/) SZSE: 300255 - [3SBio](https://aibio.space/companies/3sbio/) HKEX: 1530 - [TenNor Therapeutics Suzhou](https://aibio.space/companies/tennor-therapeutics-suzhou/) HKEX: 6872 ### Also on HKEX - [China Biotech Services Holdings](https://aibio.space/companies/china-biotech-services/) 8037 - [Modern Chinese Medicine Group Co.](https://aibio.space/companies/modern-chinese-medicine/) 1643 - [Jacobson Pharma Corporation](https://aibio.space/companies/jacobson-pharma/) 2633 - [Genscript Biotech](https://aibio.space/companies/genscript-biotech/) 1548 - [TenNor Therapeutics Suzhou](https://aibio.space/companies/tennor-therapeutics-suzhou/) 6872 - [Zai Lab](https://aibio.space/companies/zai-lab/) 9688 ## Questions about Beijing Luzhu Biotechnology Co. What is the ticker symbol of Beijing Luzhu Biotechnology Co.? Beijing Luzhu Biotechnology Co., Ltd. trades under the ticker 2480 on HKEX. Where is Beijing Luzhu Biotechnology Co. listed? Beijing Luzhu Biotechnology Co., Ltd. is listed on HKEX. Which country or territory is Beijing Luzhu Biotechnology Co. listed under? Our directory records Beijing Luzhu Biotechnology Co., Ltd. under China. What does Beijing Luzhu Biotechnology Co. do? Our directory classifies Beijing Luzhu Biotechnology Co., Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of Beijing Luzhu Biotechnology Co.? The ISIN recorded for Beijing Luzhu Biotechnology Co., Ltd. is CNE100005YD8. Does aibio.space cover Beijing Luzhu Biotechnology Co.? aibio.space lists Beijing Luzhu Biotechnology Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Beijing Luzhu Biotechnology Co.? Companies in our directory listed in the same country and business area as Beijing Luzhu Biotechnology Co.: Anhui Huaheng Biotechnology Co., CanSino Biologics, Shaanxi Micot Pharmaceutical Technology Co., Frontier Biotechnologies, Boji Medical Technology Co., Hebei Changshan Biochemical Pharmaceutical Co.. ## Investor discussion: Beijing Luzhu Biotechnology Co. Members talk about Beijing Luzhu Biotechnology Co. (2480). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Beijing Luzhu Biotechnology Co., newest first. Each line links the filing it comes from. 1. 2026-05-18 Financings Share or debt issue: CIRCULAR OF THE 2026 ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0518/2026051801688.pdf) 2. 2025-05-20 Financings Share or debt issue: CIRCULAR OF THE 2025 ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0520/2025052001227.pdf) ## Press releases Headlines of Beijing Luzhu Biotechnology Co.'s own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-10-12 HKEXnews [VOLUNTARY ANNOUNCEMENT - RECOMBINANT RSV VACCINE OBTAINS CLINICAL TRIAL APPROVAL IN CHINA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1012/2026101200881.pdf) 2. 2026-09-24 HKEXnews [SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0924/2026092401989.pdf) 3. 2026-08-26 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0826/2026082600314.pdf) 4. 2026-08-09 HKEXnews [VOLUNTARY ANNOUNCEMENT - PUBLICATION OF PHASE III CLINICAL TRIAL RESULTS OF LZ901 IN NATURE COMMUNICATIONS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0809/2026080900097.pdf) 5. 2026-06-12 HKEXnews [UPDATE ON THE QUALIFICATION OF COMPANY SECRETARY; RESIGNATION OF JOINT COMPANY SECRETARY AND CHANGE OF AUTHORISED REPRESENTATIVE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0612/2026061200536.pdf) 6. 2026-06-12 HKEXnews [POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 12, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0612/2026061200478.pdf) 7. 2026-05-18 HKEXnews [NOTICE OF 2026 ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0518/2026051801700.pdf) 8. 2026-05-18 HKEXnews [CIRCULAR OF THE 2026 ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0518/2026051801688.pdf) 9. 2026-04-23 HKEXnews [CHANGE IN USE OF PROCEEDS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0423/2026042303062.pdf) 10. 2026-03-18 HKEXnews [ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0318/2026031801520.pdf) 11. 2026-03-18 HKEXnews [ANNOUNCEMENT - CHANGE OF JOINT COMPANY SECRETARY, AUTHORISED REPRESENTATIVE AND PROCESS AGENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0318/2026031801304.pdf) 12. 2025-10-09 HKEXnews [VOLUNTARY ANNOUNCEMENT - SUCCESSFUL COMPLETION OF PHASE I CLINICAL TRIAL OF LZ901 IN THE U.S.](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1009/2025100901032.pdf) 13. 2025-09-25 HKEXnews [VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF DEPUTY GENERAL MANAGER](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0925/2025092500988.pdf) 14. 2025-08-26 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0826/2025082600405.pdf) 15. 2025-08-17 HKEXnews [VOLUNTARY ANNOUNCEMENT - POSITIVE CLINICAL DATA FOR HEAD-TO-HEAD COMPARISON STUDY OF LZ901](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0818/2025081800063.pdf) 16. 2025-06-27 HKEXnews [TERMS OF REFERENCE OF THE NOMINATION COMMITTEE](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0627/2025062702004.pdf) 17. 2025-06-27 HKEXnews [Designation of Lead Independent Non-executive Director](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0627/2025062701978.pdf) 18. 2025-06-12 HKEXnews [POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 12, 2025; ELECTION OF DIRECTORS OF THE FIFTH SESSION OF THE BOARD; AND ELECTION OF SUPERVISOR OF THE FIFTH SESSION OF THE SUPERVISORY BOARD](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0612/2025061201098.pdf) 19. 2025-05-20 HKEXnews [2025 Share Award Scheme](https://www1.hkexnews.hk/listedco/listconews/sehk/dod/en.html) 20. 2025-05-20 HKEXnews [NOTICE OF 2025 ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0520/2025052001251.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:2480 on TradingView](https://www.tradingview.com/symbols/HKEX-2480/). ## Listing details Beijing Luzhu Biotechnology Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2480, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Beijing Luzhu Biotechnology Co., Ltd. - **Ticker**: 2480 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Biotechnology - **ISIN**: CNE100005YD8 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-2480/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/beijing-luzhu-biotechnology/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Beijing Luzhu Biotechnology Co. (2480) stock and investor profile", 2026-10-31, https://aibio.space/companies/beijing-luzhu-biotechnology/